|
Leading global travel information and advice destination on the web |
Acquired |
2000 |
View Profile |
|
Large repository of human DNA, serum and tissue samples linked to detailed clinical information |
Acquired |
2000 |
View Profile |
|
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
Public |
2000 |
View Profile |
|
|
Private |
2000 |
View Profile |
|
Developing small molecule therapeutics for multiple oncology and immunology-based indications |
Acquired |
2001 |
View Profile |
|
Providing XFe Analyzers and stress test kits that are becoming the industry standard in cell metabolism measurements. |
Private |
2001 |
View Profile |
|
Pioneering the development of Systems Diagnostics (SysDx(TM)). |
Private |
2001 |
View Profile |
|
Genetically diverse organisms for agricultural, life science, and pharmaceutical use |
Acquired |
2001 |
View Profile |
|
Developing new class of therapeutic compounds. |
Acquired |
2002 |
View Profile |
|
Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. |
Public |
2002 |
View Profile |
|
Developing electronic design automation tool for high-performance virtual system prototypes |
Private |
2002 |
View Profile |
|
Machine intelligence for video security |
Acquired |
2002 |
View Profile |
|
Discovering, developing and commercializing cancer therapeutics. |
Public |
2003 |
View Profile |
|
Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. |
Public |
2003 |
View Profile |
|
Developing novel therapeutics to promote vascular repair. |
Private |
2003 |
View Profile |
|
Developing novel protein measurement systems based on Protien Epitope Tag technology |
Acquired |
2003 |
View Profile |
|
Discovering, developing, manufacturing and commercializing novel protein therapeutics for orphan diseases and cancer. |
Private |
2004 |
View Profile |
|
Offering award-winning software and consulting. |
Private |
2004 |
View Profile |
|
Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. |
Private |
2004 |
View Profile |
|
Technology leader in the commercial development of a growing portfolio of sustainable products to meet the needs of chemical and fuel markets worldwide. |
Private |
2005 |
View Profile |